© 2022 MJH Life Sciences and Dermatology Times and Multimedia Medical, LLC. All rights reserved.
© 2022 MJH Life Sciences™ , Dermatology Times and Multimedia Medical, LLC. All rights reserved.
Expert rheumatologist and dermatologist discuss biosimilars and impact of biosimilars on the field of rheumatology and dermatology.
September 16th 2022
An expert rheumatologist and a dermatologist discuss challenges to bringing biosimilars to the United States.
Roy M. Fleischmann, MD, and Joel M. Gelfand, MD, MSCE, FAAD, address the importance of clinician confidence in biosimilars.
Drs Roy M. Fleischmann and Joel M. Gelfand discuss addressing patient concerns with biosimilars and provide take-home messages to clinicians utilizing biosimilars.